Sponsored by:

Duke MMIL designs novel SPECT/CT system for 3D breast imaging

Jul 17, 2007
2007 07 17 14 38 39 706
2007 07 17 14 38 39 706
Image courtesy of Duke University Medical Center Multi-Modality Imaging Lab.

Latest in Molecular Imaging
2025 06 12 Visual Abstract Thumbnail
PSMA-PET/CT improves survival in men with prostate cancer
June 12, 2025
Ge Health Care Logo
GE HealthCare highlights combined software with MIM Encore
June 12, 2025
Alzheimer's Case Study
Sponsored
Alzheimer's Case Study
June 6, 2025
Brain Theranostics2
Radiopharm secures fast-track designation for brain PET tracer
June 11, 2025
Related Stories
2007 07 17 15 08 50 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 07 17 14 32 28 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 06 25 10 54 15 706
Molecular Imaging
Studies link Alzheimer's to beta-amyloid and potential for new ligand
Alzheimer's Case Study
Sponsor Content
Alzheimer's Case Study
More in Molecular Imaging
PSMA-PET/CT improves survival in men with prostate cancer
By Will Morton
Researchers report that PSMA-PET/CT improves survival in men with recurrent prostate cancer treated with salvage radiotherapy.
June 12, 2025
2025 06 12 Visual Abstract Thumbnail
GE HealthCare highlights combined software with MIM Encore
By AuntMinnie.com staff writers
GE HealthCare has combined its software features and algorithms with the MIM Encore platform.
June 12, 2025
Ge Health Care Logo
MolecuLight touts published research on i:X device
By AuntMinnie.com staff writers
MolecuLight is highlighting research showing the efficacy of MolecuLight's i:X device on managing deep sternal wound infections.
June 12, 2025
Molecu Light Logo
Radiopharm secures fast-track designation for brain PET tracer
By AuntMinnie.com staff writers
Radiopharm has received fast-track designation from the U.S. Food and Drug Administration for its F-18 RAD101 PET radiotracer.
June 11, 2025
Brain Theranostics2
Positrigo closes $8.5M funding round
By AuntMinnie.com staff writers
Firm also notes board changes.
June 10, 2025
Money Pile 400
Aktis secures INDs for new theranostics pair
By AuntMinnie.com staff writers
Aktis has received investigational new drug (IND) clearance for a phase IB clinical trial of a nectin-4-targeted theranostics pair.
June 9, 2025
Breast Cancer2
PET/CT supports use of infliximab for cardiac sarcoidosis
By Will Morton
FDG-PET/CT imaging has provided new evidence that infliximab is effective for treating cardiac sarcoidosis.
June 9, 2025
Cs Pet Ct y2 A Pd6 Q Oa O Thumbnail
PET tracer for prostate cancer performs well in clinical trial
By Will Morton
A new PET tracer for detecting prostate cancer performed well in a phase II/III clinical trial.
June 9, 2025
F3large 1 xj1 Zozzq In Thumbnail
Animal studies for PET drugs begin phasing out
By Will Morton
Dosing safety studies in animals for new PET radiotracers are being phased out.
June 6, 2025
Animal Testing
ASNC offers guide on use of F-18 MPI radiotracers
By AuntMinnie.com staff writers
ASNC has published a guide on the use of F-18 MPI radiotracers.
June 4, 2025
Flurpiridaz
Ionetix to invest $26M in Lansing facility development
By AuntMinnie.com staff writers
Radiopharmaceutical developer Ionetix is investing $25.8 million into Lansing, MI, and creating 53 new jobs.
June 3, 2025
Atom Nuclear Lab Social
Radium-223 safety confirmed in long-term study
By Erik L. Ridley
At ASCO 2025, researchers shared data on the long-term safety of Ra-223 treatments for metastatic castration-resistant prostate cancer.
June 2, 2025
Pxl 20250531 175048475~2
Page 1 of 606
Next Page